Valiant Organics Experiences Shift to Mildly Bullish Trend Amid Strong Profit Growth
Valiant Organics, a microcap in the specialty chemicals sector, has recently adjusted its evaluation amid changing technical trends. The company reported a 61.03% growth in operating profit and achieved record net sales of Rs 204.41 crore, despite facing long-term challenges in profit growth.
Valiant Organics, a microcap player in the specialty chemicals industry, has recently undergone an adjustment in evaluation, reflecting changes in its underlying technical trends. The stock's technical indicators have shifted, with the overall trend moving from a sideways position to a mildly bullish stance. In terms of performance metrics, Valiant Organics reported a significant operating profit growth of 61.03% in its latest quarter, contributing to a robust EBIT to Interest ratio of 12.54. The company achieved its highest net sales of Rs 204.41 crore and a peak operating profit margin of 12.15%. Despite a year-over-year return of -6.18%, the company has seen a remarkable 133.4% increase in profits, indicating a strong operational performance.
However, it is important to note that the stock has faced challenges, including a long-term decline in operating profit growth at an annual rate of -29.47% over the past five years. Additionally, domestic mutual funds hold no stake in the company, which may reflect a cautious sentiment regarding its valuation or business prospects.
For those interested in tracking the latest developments, you can Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
